A group led by Carlo Dominici has applied high‐throughput next‐generation sequencing to identify the miR transcriptome in a cohort of MYCN‐amplified and non‐amplified NB tumors (Megiorni et al., 2017). The gene discussed is MYCN; the disease is neuroblastoma.